Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Affimed N.V. (AFMD)

Affimed N.V. (AFMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 264,119
  • Shares Outstanding, K 123,420
  • Annual Sales, $ 47,760 K
  • Annual Income, $ -68,060 K
  • 60-Month Beta 2.32
  • Price/Sales 5.32
  • Price/Cash Flow N/A
  • Price/Book 1.24
Trade AFMD with:

Options Overview Details

View History
  • Implied Volatility 171.10% ( +1.86%)
  • Historical Volatility 67.54%
  • IV Percentile 92%
  • IV Rank 28.14%
  • IV High 449.94% on 09/09/22
  • IV Low 61.89% on 10/21/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 95
  • Volume Avg (30-Day) 145
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 11,829
  • Open Int (30-Day) 11,466

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.18
  • Number of Estimates 5
  • High Estimate -0.16
  • Low Estimate -0.22
  • Prior Year -0.17
  • Growth Rate Est. (year over year) -5.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.93 +11.92%
on 09/27/22
2.80 -22.86%
on 09/13/22
-0.46 (-17.56%)
since 09/02/22
3-Month
1.93 +11.92%
on 09/27/22
3.40 -36.47%
on 08/08/22
-0.65 (-23.13%)
since 07/01/22
52-Week
1.93 +11.92%
on 09/27/22
7.35 -70.61%
on 11/22/21
-3.68 (-63.01%)
since 10/04/21

Most Recent Stories

More News
Billionaires Are Scooping Up These 3 Beaten-Down Biotech Stocks

This billionaire-guided hedge fund went bargain-shopping in the second quarter.

AFMD : 2.16 (+0.93%)
CERS : 3.87 (+3.20%)
REPL : 17.69 (+3.33%)
Affimed N.V. (AFMD) Reports Q2 Loss, Lags Revenue Estimates

Affimed N.V. (AFMD) delivered earnings and revenue surprises of 22.22% and 4.22%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

AFMD : 2.16 (+0.93%)
TARS : 17.84 (+4.94%)
Affimed Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Progress

AFM13 monotherapy: On track to report topline data of the registration-directed REDIRECT trial in the fourth quarter of 2022AFM13 combination with natural...

AFMD : 2.16 (+0.93%)
Seer, Inc. (SEER) Reports Q2 Loss, Tops Revenue Estimates

Seer, Inc. (SEER) delivered earnings and revenue surprises of 5.13% and 17.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

SEER : 8.12 (+2.01%)
AFMD : 2.16 (+0.93%)
AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Lags Revenue Estimates

AnaptysBio, Inc. (ANAB) delivered earnings and revenue surprises of -21.05% and 80.84%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ANAB : 26.97 (+4.17%)
AFMD : 2.16 (+0.93%)
Affimed to Report Second Quarter 2022 Financial Results & Corporate Update on August 11, 2022

HEIDELBERG, Germany, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology...

AFMD : 2.16 (+0.93%)
Centene (CNC) Q2 Earnings Beat Estimates, Boosts 2022 View

Centene (CNC) currently has $3.4 billion remaining in its share buyback program.

MOH : 348.47 (+2.69%)
CNC : 80.87 (+1.09%)
AGEN : 2.21 (+5.74%)
AFMD : 2.16 (+0.93%)
Can Elevance Health (ELV) Beat Q2 Earnings on Membership Growth?

Elevance Health's (ELV) second-quarter results are likely to reflect improved Commercial Business operations, driven by the robust growth in risk-based areas.

CNC : 80.87 (+1.09%)
ASND : 108.59 (+9.22%)
AFMD : 2.16 (+0.93%)
ELV : 479.23 (+1.95%)
UnitedHealth (UNH) to Post Q2 Earnings: What to Expect?

UnitedHealth Group's (UNH) second-quarter results are likely to reflect improving premiums, products and higher expenses.

UNH : 523.17 (+1.49%)
CNC : 80.87 (+1.09%)
AFMD : 2.16 (+0.93%)
ELV : 479.23 (+1.95%)
Affimed Establishes Scientific Advisory Board

Independent advisory panel to be made up of distinguished, key opinion leaders with scientific and clinical expertise in innate immunity and...

AFMD : 2.16 (+0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Affimed N.V is a clinical stage biopharmaceutical company. It is engaged in developing single and combination therapies to treat cancers. The company's product pipeline consists of AFM13, AFM24, AFM26, AFM11 and AMV564 which are in clinical stage. Affimed N.V, formerly known as Affimed Therapeutics B.V.,...

See More

Key Turning Points

3rd Resistance Point 2.36
2nd Resistance Point 2.30
1st Resistance Point 2.23
Last Price 2.16
1st Support Level 2.10
2nd Support Level 2.04
3rd Support Level 1.97

See More

52-Week High 7.35
Fibonacci 61.8% 5.28
Fibonacci 50% 4.64
Fibonacci 38.2% 4.00
Last Price 2.16
52-Week Low 1.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar